Tamsulosin

Alpha-1 Adrenergic Blocker

NADAC/unit $0.0513

No Shortage Tier 1: 77.5% 12 Manufacturers 12 ANDAs

Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14)].

Covered Lives

Active Shortages

2025-04-10 Shortage reported, Sandoz Inc.

Generic Manufacturers

ALKEM LABORATORIES LTDASCENT PHARMACEUTICALS INCAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCIMPAX LABORATORIES INCMACLEODS PHARMACEUTICALS LTDRISING PHARMA HOLDINGS INCSANDOZ INCSCIEGEN PHARMACEUTICALS INCSYNTHON BVTEVA PHARMACEUTICALS USAZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Tamsulosin drfinder.aiFind doctors who prescribe Tamsulosin rxnews.aiLatest news about Tamsulosin

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.